New device aims to prevent blood type Mix-Ups at bedside
NCT ID NCT04344613
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study was designed to test a new device that checks a patient's blood type and the blood bag's type at the bedside before a transfusion. The goal was to prevent dangerous mismatched transfusions by giving a simple 'go' or 'no-go' result in about two minutes. However, the trial was withdrawn before any participants were enrolled, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ABODpoct device
What this could lead to
If it works, this device could help prevent dangerous mismatched blood transfusions by giving a quick, clear 'go' or 'no-go' result at the bedside.
What could go wrong
The trial was withdrawn before any patients were enrolled, so no data were collected. The device is still in early development and may not prove reliable in real-world use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD TRANSFUSION COMPLICATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Brugmann
Brussels, 1020, Belgium